APA (7th ed.) Citation

Zhu, Q., Duan, X., Hu, H., You, R., Xia, T., Yu, T., . . . Chen, M. (2024). EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma. Journal of Translational Medicine, 22(1), 1. https://doi.org/10.1186/s12967-024-05822-3

Chicago Style (17th ed.) Citation

Zhu, Qian, Xiao-Bing Duan, Hao Hu, Rui You, Tian-Liang Xia, Tao Yu, Tong Xiang, and Ming-Yuan Chen. "EBV-induced Upregulation of CD55 Reduces the Efficacy of Cetuximab Treatment in Nasopharyngeal Carcinoma." Journal of Translational Medicine 22, no. 1 (2024): 1. https://doi.org/10.1186/s12967-024-05822-3.

MLA (9th ed.) Citation

Zhu, Qian, et al. "EBV-induced Upregulation of CD55 Reduces the Efficacy of Cetuximab Treatment in Nasopharyngeal Carcinoma." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12967-024-05822-3.